Implementation workshop of WHO guidelines on evaluation of malaria vaccines: Current regulatory concepts and issues related to vaccine quality, Pretoria, South Africa 07 Nov 2014
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- WHO
This publication has 7 references indexed in Scilit:
- Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African SitesPLOS Medicine, 2014
- Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of ProtectionThe Journal of Infectious Diseases, 2009
- Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.The Journal of Immunology, 1995
- Antibodies to the Circumsporozoite Protein and Protective Immunity to Malaria Sporozoites1993
- Protective anti-sporozoite antibodies induced by a chemically defined synthetic vaccineImmunology Letters, 1990
- Inhibition of entry of Plasmodium falciparum and P. vivax sporozoites into cultured cells; an in vitro assay of protective antibodies.The Journal of Immunology, 1984
- Hybridoma Produces Protective Antibodies Directed Against the Sporozoite Stage of Malaria ParasiteScience, 1980